Depo-Medrol®
Depo-Medrol® is a medical device with 8 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
1
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial
Depo-Medrol on Psoas After LLIF
EuroPainClinics® Study II (Prospective Trial)
A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults
AlloGen-LI Treatment of Spinal Stenosis
Clinical Trials (8)
ACP Max™ PRP System for Knee Osteoarthritis: A Feasibility Trial
Depo-Medrol on Psoas After LLIF
EuroPainClinics® Study II (Prospective Trial)
A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults
AlloGen-LI Treatment of Spinal Stenosis
Does Injection Site Matter? A Randomized Controlled Trial to Evaluate Efficacy of Knee Intraarticular Injections on Improval of Patient Reported Outcomes.
Effectiveness of Steroid Injection in Treating Patients With Lateral Epicondylitis
Epidural Study of Patients With Chronic Lower Back Pain
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8